Antithrombotic therapy (aspirin, P2Y12 inhibitor, heparin) was carefully balanced to prevent stent thrombosis without causing hemorrhage, with no major bleeding or stroke hemorrhagic conversion occurring. The gene discussed is P2RY12; the disease is Stroke.